|
Opsoclonus Myoclonus Syndrome (OMS), also known as Opsoclonus-Myoclonus-Ataxia (OMA), is a rare neurological disorder of unknown causes which appears to be the result of an autoimmune process involving the nervous system. It is an extremely rare condition, affecting as few as 1 in 10,000,000 people per year. It affects 2 to 3% of children with neuroblastoma and has been reported to occur with celiac disease. ==Nomenclature== OMS was first described by Marcel Kinsbourne in 1962. (The term 'Opsoclonus' was coined by Orzechowski in 1913, but it was classically described and associated with neuroblastoma by Kinsbourne). Other names for OMS include: *Opsoclonus-Myoclonus-Ataxia(OMA) *Paraneoplastic Opsoclonus-Myoclonus Ataxia (POMA) *Kinsbourne syndrome *Myoclonic Encephalopathy of Infants *Dancing Eyes-Dancing Feet syndrome *Dancing Eyes syndrome Nystagmus 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Opsoclonus myoclonus syndrome」の詳細全文を読む スポンサード リンク
|